PASTILLE DESINFECTANTE, COMPACTE ET SECABLE
    1.
    发明公开
    PASTILLE DESINFECTANTE, COMPACTE ET SECABLE 有权
    一项违反GROOVE的紧凑消毒片

    公开(公告)号:EP1858321A1

    公开(公告)日:2007-11-28

    申请号:EP06726078.6

    申请日:2006-03-13

    申请人: Eurotab

    IPC分类号: A01N25/08 A01N25/12

    摘要: The invention relates to a compact composition in the form of a tablet, comprising at least one disinfectant agent, said tablet having a mass of between 1.5 and 3 g and a height of between 2.5 and 7 mm. The invention is characterised in that: the tablet has a breaking strength of between 55 and 95 N, and at least one of the faces of the tablet is provided with a scored line that divides the tablet into two halves. The invention also relates to a method of producing a compact composition in the form of a scored tablet comprising two essentially-identical halves, containing at least one disinfectant agent. The inventive method is characterised in that it comprises the following steps consisting in: a°) preparing between 1.5 and 3 g of a mixture of powders comprising at least one disinfectant agent; and b°) compacting the mixture obtained in a°) in a tablet machine at a compression force of between 20 and 35 kN., in order to obtain the tablet, and stamping at least one scored line on at least one of the faces thereof, thereby dividing the tablet into two halves. The invention further relates to a composition that can be obtained using said method.

    TABLETTE MULTICOUCHE À COUCHES DE FRAGMENTATION
    3.
    发明公开
    TABLETTE MULTICOUCHE À COUCHES DE FRAGMENTATION 有权
    衰变层多层片

    公开(公告)号:EP2044189A2

    公开(公告)日:2009-04-08

    申请号:EP07803874.2

    申请日:2007-07-16

    申请人: Eurotab

    摘要: The present invention relates to a solid multilayer tablet adapted for disintegrating in a liquid for releasing a pharmaceutical agent within said liquid, wherein said tablet comprises at least n disintegration layers, wherein n is an integer at least equal to 1, and at least (n+1) product layers, wherein said (n+1) product layers have the same composition, wherein each product layer comprises at least said pharmaceutical agent and each disintegration layer is disposed between two product layers, and wherein the disintegration rate of said disintegration layer is significantly higher than that of said product layers, characterized in that: each disintegration layer comprises at least one disintegrant, wherein the content of said disintegrant in said disintegration layer is more than or equal to 25 % per weight with respect to the weight of said disintegration layer.